#United States #Washington, D.C. #health research #Independent Medical Alliance #Journal of Independent Medicine

Independent Medical Alliance Releases Fourth Edition of the Journal of Independent Medicine

On November 12, 2025, the Independent Medical Alliance (IMA) proudly announced the launch of Volume 1, Issue No. 4 of the Journal of Independent Medicine. This milestone marks the successful continuation of four quarterly publications within its inaugural year, establishing the journal as a crucial scientific platform for physicians, researchers, and patients who seek objective, evidence-based research free from corporate and political biases.

Dr. Joseph Varon, the Editor-in-Chief of the Journal and President of IMA, articulated the significance of this publication in light of growing concerns about transparency in healthcare. He stated, "As federal agencies like HHS increasingly prioritize transparency and conflict-free science, the Journal of Independent Medicine addresses the void created by institutions that are often compromised." This new edition promises to publish thorough, peer-reviewed studies that contest existing assumptions, foster open discussion, and transition more attention towards independent medicine from traditional, often biased, scientific sources.

What sets the Journal of Independent Medicine apart is its commitment to examining underreported issues. Topics covered in this publication include vaccine safety, the prevention of chronic diseases, and medical ethics — all rigorously peer-reviewed and free from pharmaceutical sponsorship. This ensures that the scientific discourse remains unbiased and accessible to both healthcare professionals and the public.

Looking ahead to 2026, IMA plans to amplify the journal’s impact by increasing its frequency to six editions a year, including two special issues focused on critical and often underserved areas of healthcare.

The themes for these upcoming editions include:

• - Treating Post-Vaccine Complications
• - Repurposed Drugs and Nutraceuticals in Addressing the Chronic Disease Epidemic

Dr. Varon emphasized how these future discussions aim to empower both physicians and patients with the knowledge necessary for informed decisions and effective care. He remarked, "By focusing on neglected areas in healthcare, we aim to rebuild trust and lay the groundwork for meaningful reform."

Featured Articles in Volume 1, Issue No. 4

This edition includes several impactful articles ranging from thorough reviews to original studies:

• - Considering the Safety of COVID-19 mRNA Vaccines in Patients with Aneuploidy (Martin J. McCaffrey): This article investigates how genetic anomalies may influence mRNA vaccine mechanisms and highlights new considerations for ensuring patient safety.
• - Preventing Cancer: The ROOT Protocols (Paul Marik & Justus Hope): This piece outlines strategies for cancer risk reduction through lifestyle changes and the use of nutraceuticals along with repurposed drugs.
• - A Holistic Approach to Improve Metabolic Health: A Practical Review (Pei Harris & Joseph Varon): A comprehensive guide aiming to reverse metabolic syndrome through nutritional, lifestyle, and integrative therapies.
• - Beyond the Dead Donor Rule: Medicine, Ethics, and the Future of Organ Procurement (Joseph Varon & Matthew Halma): Analyzing the ethics surrounding organ donation protocols, this article emphasizes the implications for modern medical practices.
• - Vaccine-Induced Viral Reactivation and Autism Spectrum Disorder (Matthew Cormier): This review delves into potential connections between viral reactivation following vaccinations and neurodevelopmental disorders.
• - A Non-Isolated Call for Rigor: The History of the 'Anti-Vaccination Movement' and Its Path to Legitimacy (Matthew Halma & Joseph Varon): Reflecting on the necessary professionalization and scientific standards for credible medical freedom advocacy.
• - Palliative Care in Iraq: A Health Systems Imperative for Equity in Fragile and Conflict-Affected Settings (Santiago Herrero): This article documents urgent needs for health equity in end-of-life care in the context of conflict areas.

Additionally, original articles like Metacritique of Influential Studies Purporting COVID-19 Vaccine Successes Part 3 (Raphael Lataster) provide a critical examination of methodologies surrounding vaccine efficacy claims. The journal also shares important case reports, including one on Cavernous Dural Arteriovenous Fistula Following COVID-19 mRNA Vaccination (Dean Patterson et al.), highlighting neurological complications that could arise.

Letters to the editor present further community engagement, illustrated by Hal Switkay's analysis on the rising rate of disabilities within the American civilian labor force, calling for a public health investigation.

All editions of the Journal of Independent Medicine, including the current one, are available free of charge at www.JIndepMed.org. This journal represents a sanctuary for scientific truth, free from pharmaceutical interests and political biases, committed to prioritizing patients over profits and providing rigorously validated research.

About the Journal of Independent Medicine

The Journal of Independent Medicine is published quarterly by the Independent Medical Alliance™ and serves as a beacon for scientific authenticity. Guided by a global editorial board consisting of 43 experts from 17 countries across various specialties, this journal is focused on delivering research that champions patient welfare and well-being.

About the Independent Medical Alliance (IMA)

As a nonprofit organization under 501(c)(3) status, IMA comprises a united coalition of doctors, scientists, and other healthcare professionals devoted to restoring trust and transparency in healthcare. With a commitment to Honest Medicine™, IMA prioritizes patients over profits, striving for long-term health and effective disease prevention. Their advocacy efforts were notably impactful during recent national health policy discussions, successfully mobilizing grassroots actions across the country.